Di Min (迪皿)迪皿
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 重庆华邦制药有限公司Chinese legal name: 重庆华邦制药有限公司
主要成分Active Ingredients
- 左西替利嗪Zuoxi Tili Qin
药物知识说明
左西替利嗪是一种在国家药监局注册认定的药品。该药品含有左西替利嗪-bafc6d00等成分。
该药品关联的活性成分包括：左西替利嗪Zuoxi Tili Qin。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：重庆华邦制药有限公司Chinese legal name: 重庆华邦制药有限公司。
您可以探索含有相同成分的其他药品：左西替利嗪-bafc6d00成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 迪皿) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 左西替利嗪Zuoxi Tili Qin.
Manufacturers recorded for this product: 重庆华邦制药有限公司Chinese legal name: 重庆华邦制药有限公司.
Explore other medicines containing the same ingredient: 左西替利嗪 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 迪皿Recorded Chinese name: 迪皿
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 5mg*9片5 mg × 9 tablets
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 重庆华邦制药有限公司Chinese legal name: 重庆华邦制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20040249
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20040249
Manufacturer
Chinese legal name: 重庆华邦制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20040249
生产企业
重庆华邦制药有限公司(国产)
适应症
本品耐受性良好，不良反应轻微且多可自愈，常见不良反应有嗜睡、口干、头痛、乏力等。
用法用量
口服，成人及6岁以上儿童用量为每日一次，每次1处。2-6岁儿童，每日一次，每次半片。
不良反应
本品可能会使个别患者产生头痛、嗜睡、口干、疲倦、衰弱、腹痛等不良反应。
禁忌
对本品及其它辅料过敏者禁用。
注意事项
1.有肝功能障碍或障碍史者慎用。
2.高空作业、驾驶或操纵机器期间慎用。
3.避免与镇静剂同服。
4.酒后避免使用本品。
5.肾功能减损患者使用本品适当减量。
贮藏
密封、在干燥处保存。
规格
5mg*15s*1板
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.